Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
2.980
-0.160 (-5.10%)
Sep 6, 2024, 4:00 PM EDT - Market closed
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $26.59 million as of September 6, 2024. Its market cap has decreased by -49.93% in one year.
Market Cap
26.59M
Enterprise Value
18.79M
1-Year Change
-49.93%
Ranking
Category
Stock Price
$2.98
Market Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $26.59M, a decrease of -41.94%. That is a compound annual growth rate of -6.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 6, 2024 | 26.60M | -45.60% |
| Dec 29, 2023 | 48.90M | 120.27% |
| Dec 30, 2022 | 22.20M | -71.86% |
| Dec 31, 2021 | 78.90M | 13.36% |
| Dec 31, 2020 | 69.60M | -47.15% |
| Dec 31, 2019 | 131.70M | -47.70% |
| Dec 31, 2018 | 251.80M | 509.69% |
| Dec 29, 2017 | 41.30M | 27.08% |
| Dec 30, 2016 | 32.50M | -29.04% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chemomab Therapeutics | 27.21M |
| ReWalk Robotics | 27.11M |
| Gain Therapeutics | 26.81M |
| IGC Pharma | 26.70M |
| HCW Biologics | 26.62M |
| Enlivex Therapeutics | 26.52M |
| Mobile-health Network Solutions | 26.52M |
| Incannex Healthcare | 26.35M |